NCT05753475

Brief Summary

The aim of the researchers was to evaluate the adequacy of graft function in the postoperative period of patients who underwent renal transplantation and encountered hypotension in the intraoperative period.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 21, 2023

Completed
8 days until next milestone

Study Start

First participant enrolled

March 1, 2023

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 3, 2023

Completed
29 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2023

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2024

Completed
Last Updated

March 3, 2023

Status Verified

March 1, 2023

Enrollment Period

1 month

First QC Date

February 21, 2023

Last Update Submit

March 1, 2023

Conditions

Renal Transplant Failure and RejectionHypotension

Outcome Measures

Primary Outcomes (5)

  • Systolic Blood Pressure

    baseline

  • Mean Arterial Pressure

    baseline

  • Systolic Blood Pressure

    during the surgery

  • Mean Arterial Pressure

    during the surgery

  • graft function

    immediately after the surgery

Study Arms (2)

hypotension

Other: renal transplantation

normotension

Other: renal transplantation

Interventions

renal transplantationOTHER

patients undergoing renal transplantation

hypotensionnormotension

Eligibility Criteria

Age12 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients undergoing renal transplantation

You may qualify if:

  • patients undergoing renal transplantation

You may not qualify if:

  • patient refusal

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara City Hospital

Ankara, 06800, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Rejection, PsychologyHypotension

Interventions

Kidney Transplantation

Condition Hierarchy (Ancestors)

Social BehaviorBehaviorVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Renal Replacement TherapyTherapeuticsOrgan TransplantationTransplantationSurgical Procedures, OperativeUrologic Surgical ProceduresUrogenital Surgical Procedures

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

February 21, 2023

First Posted

March 3, 2023

Study Start

March 1, 2023

Primary Completion

April 1, 2023

Study Completion

February 1, 2024

Last Updated

March 3, 2023

Record last verified: 2023-03

Locations

TU(1)